Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research, manufacture, and export of pharmaceutical APIs in Asia. It primarily provides corticosteroid, cardio cerebrovascular, and analgesic APIs and formulations. The company offers bulk drugs, including dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinlone acetonide acetate, prednisone acetate, prednisone, prednisolone, flucinonide, halcinonide, triamcinolone acetonide, clobetasol propionate, betamethasone, methylprednisolone hydrocortisone acetate, methylprednisolone, and triamcinolone. The company is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE : 600488) operates as a subsidiary of Jinhushen Biomedical Technology Co., Ltd.
Tianjin Tianyao Pharmaceuticals Dividend Announcement
• Tianjin Tianyao Pharmaceuticals announced a annually dividend of ¥0.09 per ordinary share which will be made payable on 2024-06-14. Ex dividend date: 2024-06-14
• Tianjin Tianyao Pharmaceuticals annual dividend for 2024 was ¥0.09
• Tianjin Tianyao Pharmaceuticals annual dividend for 2023 was ¥0.01
• Tianjin Tianyao Pharmaceuticals's trailing twelve-month (TTM) dividend yield is 1.96%
• Tianjin Tianyao Pharmaceuticals's payout ratio for the trailing twelve months (TTM) is 106.65%
• Tianjin Tianyao Pharmaceuticals's dividend growth over the last five years (2018-2023) was -22.60% year
• Tianjin Tianyao Pharmaceuticals's dividend growth over the last ten years (2013-2023) was -6.70% year
Tianjin Tianyao Pharmaceuticals Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-06-14 | ¥0.09 | annually | 2024-06-14 |
2023-05-11 | ¥0.01 | annually | 2023-05-11 |
2022-05-11 | ¥0.01 | annually | 2022-05-11 |
2021-05-25 | ¥0.01 | annually | 2021-05-25 |
2020-04-30 | ¥0.04 | annually | 2020-04-30 |
2019-05-15 | ¥0.06 | annually | 2019-05-15 |
2018-06-12 | ¥0.04 | annually | 2018-06-12 |
2017-05-10 | ¥0.02 | annually | 2017-05-10 |
2016-05-20 | ¥0.03 | annually | |
2015-05-22 | ¥0.03 | annually | |
2014-05-21 | ¥0.02 | annually | |
2013-03-13 | ¥0.02 | annually |
Tianjin Tianyao Pharmaceuticals Dividend per year
Tianjin Tianyao Pharmaceuticals Dividend growth
Tianjin Tianyao Pharmaceuticals Dividend Yield
Tianjin Tianyao Pharmaceuticals current trailing twelve-month (TTM) dividend yield is 1.96%. Interested in purchasing Tianjin Tianyao Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:
Tianjin Tianyao Pharmaceuticals Financial Ratios
Tianjin Tianyao Pharmaceuticals Dividend FAQ
Other factors to consider when evaluating Tianjin Tianyao Pharmaceuticals as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Tianjin Tianyao Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Tianjin Tianyao Pharmaceuticals's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Tianjin Tianyao Pharmaceuticals publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Tianjin Tianyao Pharmaceuticals distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Tianjin Tianyao Pharmaceuticals are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Tianjin Tianyao Pharmaceuticals sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Tianjin Tianyao Pharmaceuticals distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Tianjin Tianyao Pharmaceuticals declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Tianjin Tianyao Pharmaceuticals's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Tianjin Tianyao Pharmaceuticals's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.